Arcus
arcus.xyz
Actively hiring
Cryptocurrencies
Online Brokerage & Trading Platforms
As featured in
View 2 jobs
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$13M
1 round on record
Latest round
$13M
Venture round · Aug 2019 · 7 yr ago
Team
11-50
employees, estimated range
Hiring now
2
open roles
The money's age
Long since its last round
86 months since the last round · hiring slowed
Momentum
25/100
a new city, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 1, 2019
Raised a round Venture round $13M · Business Insider
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Hacker News stories
1
best: 1 points
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2019 | $13M | — | Business Insider |
Registers and programsofficial lists and records that name the company
| Legal entity | Pocket Protector Labs Inc. | its site |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Trade the latest memecoins, trending tokenized stocks, and leverage — all in one mobile-first app. Discover, evaluate, and buy coins on…
Browse the newest fixed-supply tokens launched on Robinhood Chain.
Easy Lightning payments, 24/7.. Lexe is an easy-to-use, self-custodial Bitcoin and Lightning wallet with free node hosting and 24/7 uptime…
Discover your trading potential with cross-exchange auto copy trading platform. Generate alpha and make impactful decisions through…
A central limit order book for crypto perpetual futures, with cross-margin and settable leverage. API-first and agent-native.
Trade crypto securely on OneBullEx. Access spot & futures markets, top trading pairs, fast execution, and institutional-grade security.
News
Arcus Biosciences, Inc. Announces New Data for Casdatifan as Treatment for Kidney Cancer Across Multiple Lines of Therapy
Read more
Report
Arcus Biosciences stock holds steady as investors eye latest clinical and earnings signals
Arcus Biosciences stock remains steady on Nasdaq as of September 20, 2026 while investors focus on recent quarterly figures and the company's cash position. The latest reported revenue and loss figures frame expectations ahead of the next catalyst.
Read more
Report
Arcus Printers Introduces Innovative Monarch FB1218 UV Flatbed Printer System with Rotary Attachment
Read more
Report
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
HAYWARD, Calif., August 26, 2026--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, a
Read more
Report
Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
Read more
Report
Arcus x Robinhood: Trade Stocks & Perpetuals, 24/7 - Arcus
Trade Stock Tokens and perpetuals 24/7 on Arcus, a new decentralized exchange built on Robinhood Chain.
Read more
Report
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD-L1/VEGF-A Bispecific Immunomodulator to Treat Kidney Cancer
Arcus Biosciences, Inc., a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced a clinical trial collabor
Read more
Report
Arcus Biosciences President Sells $2 Million as Stock Delivers 48% Annual Return
Arcus Biosciences, a clinical-stage oncology innovator, reported significant insider selling as its stock capped a strong one-year return.
Read more
Report
Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update
Arcus Biosciences, Inc., a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, today reported financial results for the t
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Arcus over the last 12 months, by layer, with the share of postings for each.
Technologies in use
15
Postings analysed
2
Stack modernity
76/100
Languages
JavaScript
TypeScript
Kotlin
Swift
Frameworks & libraries
React Native
React Query
React.js
Redux
Zustand
Cloud & platforms
Figma
Framer
Practices & domains
DeFi
State Management
CI/CD
Other
dYdX
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
55/100
Growing
Open positions
2
0 opened / 1 closed in 30 days
Median time-to-fill
1328 days
faster than 3% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Design
100% ▲
Activity Timeline
New location: United States
Sep 2026
Added Rest API to stack
Sep 2026
Added Framer to stack
Sep 2026
Added Figma to stack
Sep 2026
Added Stripe to stack
Sep 2026
Added Amazon S3 to stack
Aug 2026
Added Terraform to stack
Aug 2026
Added Datadog to stack
Aug 2026
Added AWS to stack
Aug 2026
Added Amazon EC2 to stack
Aug 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
New York
New York
United States
HQ
2 open roles 100% engineering 10-50 est. staff
hires for Backend, Mobile
Jobs
$60k – $120k per year • Hybrid • Contractor • United States
DeFi
dYdX
Design
Figma
Framer
Management
Stripe
Apply
≈ $156k – $268k per year (Estimated) • Equity • Hybrid • Full-Time • 5+ years exp • New York
JavaScript
Kotlin
TypeScript
Swift
Zustand
Redux
React.js
React Query
Mobile
React Native
State Management
DevOps
CI/CD
Web3
DeFi
dYdX
Management
Stripe
Apply
Financials
Total raised
$13M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2019 | $13M | Details |